FDA Adverse Event Malfunction Summary report: N

PD CYCLER 110 VOLT HOME CHOICEPRO AUTOMATED

MDR report key: 1971074 · Received January 26, 2011

Report

Report Number
1423500-2011-01044
Event Type
Malfunction
Date Received
January 26, 2011
Date of Event
December 13, 2010
Report Date
January 3, 2011
Manufacturer
BAXTER HEALTHCARE - SINGAPORE
Product Code
FKX
PMA / PMN Number
K053512
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
FL, US
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

(B)(4). EVALUATION OF THE DEVICE HAS BEGUN; HOWEVER, HAS NOT YET BEEN COMPLETED. UPON COMPLETION OF THE EVALUATION A FOLLOW UP MEDWATCH WILL BE SUBMITTED.

Additional Manufacturer Narrative · 1

(B)(4). THE FOLLOWING INFORMATION WAS INADVERTENTLY OMITTED FROM THE INITIAL REPORT: ON (B)(6) 2011, PRODUCT SURVEILLANCE CONTACTED THE CAREGIVER (CG) WHO STATED THAT THERAPY HAS BEEN GOING WELL. THERE WAS NO PATIENT INJURY OR MEDICAL INTERVENTION ASSOCIATED WITH THIS EVENT. EVALUATION: THE PRODUCT ANALYSIS LABORATORY (PAL) EVALUATED THE HC. A REVIEW OF THE DEVICE LOGS REVEALED ONE INSTANCES OF IIPV (INCREASED INTRA-PERITONEAL VOLUME). THE PROBABLE CAUSE FOR THE IIPV FOUND IN THE DEVICE LOG WAS NOT DETERMINED. A SERVICE HISTORY REVIEW REVEALED THE PREVIOUS RETURN OF THE DEVICE WAS NOT FOR ANY ISSUES RELATED TO IIPV. THE DEVICE WAS IN SPECIFICATION RELATIVE TO IIPV FOUND IN THE LOG. BAXTER HAS CONDUCTED A TREND REVIEW AND FOUND THAT SIMILAR REPORTS HAVE BEEN RECEIVED FOR THE REPORTED PROBLEM. THE ROOT CAUSE INVESTIGATION IS IN PROGRESS THROUGH ((B)(4)).

Description of Event or Problem · 1

AN INSTANCE OF INCREASED INTRA-PERITONEAL VOLUME (IIPV) WAS IDENTIFIED DURING A REVIEW OF THE RETURNED HOMECHOICE (HC) PATIENT EVENT LOG. ON (B)(6) 2010, THE ULTRAFILTRATION WAS 1892 ML DURING CYCLE 3.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 PD CYCLER 110 VOLT HOME CHOICEPRO AUTOMATED SET, ADMINISTRATION, FOR PERITONEAL DIALYSIS, DISPOSABLE FKX BAXTER HEALTHCARE - SINGAPORE

Patients

Seq Age Sex Outcome Treatment
1 59 YR